Tianjin Pharmaceutical Holdings (TPH)

M&A

Jinhushen Bio completes 67% acquisition with Tianjin Pharma, S shares offer price revised

The S shares offer price is revised from 89.3 US cents ($1.20) to 89.4 US cents due to a computation mistake.
Jinhushen Biological Medical Science and Technology to acquire 67% stake in Tianjin Zhong Xin’s controlling shareholder for undisclosed sum - THE EDGE SINGAPORE

M&A

Jinhushen Biological Medical Science and Technology to acquire 67% stake in Tianjin Zhong Xin’s controlling shareholder for undisclosed sum

As at Dec 20, TPH holds an interest of 42.8% of the total number of issued shares in the capital of Tianjin Zhong Xin.
×